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Abstract
Background: The needs of the growing population of complex patients with multiple chronic conditions calls for a
different approach to care. Clinical teams need to acknowledge, respect, and support the work that patients do and
the capacity they mobilize to enact this work, and to adapt and self-manage. Tools that enable this approach to care
are needed.
Methods: Using user-centered design principles, we set out to create a discussion aid for use by patients, clinicians,
and other health professionals during clinical encounters. We observed clinical encounters, visited patient homes, and
dialogued with patient support groups. We then developed and tested prototypes in routine clinical practice. Then we
refined a final prototype with extensive stakeholder feedback.
Results: From this process resulted the ICAN Discussion Aid, a tool completed by the patient and reviewed during the
consultation in which patients classified domains that contribute to capacity as sources of burden or satisfaction;
clinical demands were also classified as sources of help or burden. The clinical review facilitated by ICAN generates
hypotheses regarding why some treatment plans may be problematic and may not be enacted in the patient’s situation.
Conclusion: We successfully created a discussion aid to elucidate and share insights about the capacity patients have to
enact the treatment plan and hypotheses as to why this plan may or may not be enacted. Next steps involve
the evaluation of the impact of the ICAN Discussion Aid on clinical encounters with a variety of health professionals
and the impact of ICAN-informed treatment plans on patient-important outcomes.
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Background
In part due to the successes of public health and health
care and to the ageing of the population, the incidence
of multiple chronic conditions (MCC) is increasing: 3 in
4 Americans 65 and older live with MCC, and the preva-
lence is increasing also in younger people [1, 2]. In an
era in which adults are more likely to live with chronic
conditions than not, health can no longer be defined as
the absence of disease. Instead, a new definition has
been proposed: the ability to adapt and to self-manage
[3]. The epidemic of MCCs and this new definition re-
quire a dramatic shift in the culture of providing care:
when health care cannot cure, it must instead under-
stand and develop the capacity of patients to adapt and
self-manage to the chronic conditions that almost inevit-
ably will enter their lives.
Minimally Disruptive Medicine (MDM) and its under-
pinning conceptual model, the Cumulative Complexity
Model provide practitioners with useful heuristics to
approach this shift [4, 5]. First, there is significant, un-
derappreciated, patient work necessary to implement
care plans, particularly as conditions and demands accu-
mulate [6, 7]. Attending appointments, taking medica-
tions, shopping for and preparing healthy food, enacting
an active lifestyle, dealing with administrative tasks re-
lated to insurance, scheduling appointments, refilling
prescriptions, and self-monitoring are activities that take
time, effort, sense-making, and attention [8, 9]. This
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patient work must be enacted along with the work re-
quired to fulfill roles in life. Second, patients must invest
capacity - effort, time, emotion, help, and attention - to
implement life and patient work. This capacity may be
reduced by their illness from symptoms of fatigue, pain,
or general functional decline; it may also be reduced by
lack of money or stable housing, and other forms of
scarcity [5]. With enough capacity to face the extant
workload patients can access and use healthcare and en-
act self-care, which has favorable downstream conse-
quences on health outcomes [5]. If workload exceeds
capacity, the opposite can be true. Indeed, when health
care is unable to note that poor outcomes are a conse-
quence of the imbalance of workload and capacity, treat-
ment may be intensified, worsening the situation [5].
The Burden of Treatment Theory further illuminates
patients’ capacity to adapt and self-manage by illustrat-
ing that it is not simply the presence or absence of re-
sources. Rather, it proposes that capacity is critically
dependent on the social settings in which it operates,
hinging on the patient’s social skill and social network
[10]. The concepts of workload, capacity, and treatment
burden, are complex, interdependent, and subjective. Be-
cause of this, measuring patient capacity or treatment
burden will only have partial value to clinicians and
healthcare professionals who seek to partner with their
patients to understand their situation and consider ways
to improve it. Yet, the brevity and crowding of tasks typ-
ical of clinic visits offer little to these patients beyond
technical solutions to specific complaints. Although dy-
namic, clinicians must gain an understanding of the pa-
tient capacity at this time. The difficulty of this task to
both patients and clinicians is well documented [11–15].
A partnership between patients and clinicians appears
necessary to successfully care for patients with MCC
[4, 16, 17]. This partnership requires a different conver-
sation, accomplished in the same brief and crowded en-
counters designed historically to address the technical,
acute problems of health. Tools and techniques that en-
able the effective and efficient conversations necessary to
assess patient capacity and to use this understanding to
advance plans that are more likely to be implemented and
have impact are needed.
Therefore, the aim of this study was to develop a discus-
sion aid for use during the encounter between patients,
clinicians, and other health professionals to understand
patient capacity, workload, and treatment burden.
Methods
The development process for the ICAN Discussion Aid
took place in clinical practice at Mayo Clinic and various
community locations in Olmsted County, Minnesota. All
clinicians involved consented to observation of their clinical
encounters, and, where applicable, to the use of a design
prototype during the encounter. Patients were eligible for
inclusion in the study if they had at least one chronic con-
dition. While Minimally Disruptive Medicine primarily fo-
cuses on patients with multiple chronic conditions, it seeks
to recognize complexity in life that often complicates
healthcare plans. For this reason, we did not exclude pa-
tients with only one chronic condition to capture pa-
tients who might have life complexity complicating care
even with a single condition. Patients with cognitive impair-
ments or any other barrier to informed consent were ex-
cluded from participation. All patients that were observed
during clinical encounters, home visits, and support groups
consented to participation in the study. The Mayo Clinic
Institutional Review Board approved the study procedures.
We used a two-part development process, illustrated
in Fig. 1. One component, reported elsewhere, was a
Fig. 1 Discussion Aid Development Process
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systematic review of 110 qualitative studies reporting in-
sights that bear on the concept of patient capacity.
Briefly, that review highlighted the importance of patient
Biography, Resources, Environment, accomplishing pa-
tient and life Work, and Social Functioning (BREWS),
for advancing patients’ capacity [18]. The second compo-
nent, the focus of this report, was the user-centered de-
sign of a discussion aid about patient capacity. We have
used this design approach in the development of deci-
sion aids for use during clinical consultations [19, 20].
The design process took place in four phases, and began
with direct observations (phase I). These included obser-
vations of 1) clinical encounters in primary care (n = 15),
aimed at understanding if and how matters related to pa-
tient capacity were discussed in clinical care; and 2) obser-
vations of nurse home visits with patients (n = 5), aimed at
understanding if and how matters of patient capacity were
discussed in the patients’ home. Because of the pertinent
setting, we assumed conversations in patient homes would
be richer than similar ones in the clinic. We also observed
two patient support groups to understand how patients
talked about their capacity to handle the work of chronic
disease with their peers. At the conclusion of these obser-
vations, we debriefed and reviewed our findings with our
patient advisory group, ten community members with
chronic conditions [21].
Based on our observations in phase I, we generated
three prototypes. We hypothesized that each one, when
used in conversations, could draw out patient capacity.
To evaluate these, we partnered with two primary care
clinicians (SVA, MRM), who were selected based on a
long-standing interest in Minimally Disruptive Medicine
and willingness to alter their clinical routines during
prototyping. We observed two to three clinical encoun-
ters with each prototype per clinician during this phase
(phase II, n = 15). Phase II informed new hypotheses and
three new prototypes, building on parts of the conversa-
tion that worked well and abandoning those that did
not. These prototypes were used by the same two clini-
cians in subsequent encounters (phase III, n = 13).
During phase III, one prototype showed promise for il-
luminating the dynamic interplay of patient capacity and
treatment burden, and we sought to further refine it
(phase IV, n = 5). After three additional iterations with
this prototype, we were satisfied with the 9th prototype,
deeming it the final version. We conducted observations
of the 8th and 9th prototype in use, for which we re-
cruited two additional primary care clinicians and four
specialty care clinicians (phase IV, n = 13). Additionally,
we conducted observations with the 9th prototype in
the practice of a group of wellness coaches seeing pa-
tients with chronic conditions to explore the feasibility
and pertinence of its use by other health professionals
(phase IV, n = 13).
Results
Phase I
Characteristics of patients in all clinical encounter obser-
vations that informed design are shown in Table 1. Pa-
tients ranged in ages from 18 to 87, with a mean age of
51.3 and had an average of 4.6 chronic conditions
(range 1–11). It is important to also note that in
addition to medical complexity, 32.4 % of these patients
had known non-medical complexity, such as family dis-
tress, financial problems, housing issues, or complex
substance abuse histories. We did not seek to target
specific conditions and a wide variety were represented
including, but not limited to: diabetes, COPD, depres-
sion, anxiety, hypertension, heart failure, fibromyalgia,
and other chronic pain conditions.
Four key findings resulted from Phase I observations
in clinical encounters. First, information about patients’
capacity and context sometimes arose naturally, but hap-
hazardly throughout the visit. Second, patients exhibited
learned behaviors in relation to the medical encounter.
Patients who spoke freely and enjoyed talking about
their life upon meeting them, changed completely during
the encounter. There, they spoke only of their medical
conditions and immediate concerns, and none of the life
issues they had mentioned to us previously. This is in
part in response to clinicians’ choice of opening ques-
tions. For example, “what can I do for you today?”
yielded clinical requests. Since clinicians may be less
likely to be able to “do” something about the patient’s
life challenges, these simply did not arise. Fourth, assess-
ments that offered insights about the patient’s capacity
were not used for this purpose. For example, in one
encounter, the patient had filled out multiple ques-
tionnaires, one regarding depression, one regarding
anxiety, and one regarding alcohol consumption. Des-
pite being available during the encounter, these were
never reviewed or discussed.
Table 1 Patient Demographic Characteristics
Patient demographics clinical encounters (n = 74)
Age, mean (SD) 51.3 (18.0)
Number of Conditions, mean (SD) 4.6 (2.5)
Male 23.0 %
Non-Medical Complexity (i.e., family distress, housing
problems, complex substance abuse history)
32.4 %
Race/Ethnicity
White/Not Hispanic 93.2 %
White/Hispanic 2.7 %
Other Hispanic Origin 1.4 %
African American 1.4 %
Unknown 1.4 %
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During the home visit observations, we met patients
who were the recipients of resources from the healthcare
or public health system (e.g., home health services, house-
keeping services, physical aids). Despite these resources in
support of each patient’s capacity, not all patients were
doing well. The noticeable difference between home visits
in which nurses and patients appeared more successful
conversationally and those that did not was the effort the
nurse made in extracting what gave the person’s life mean-
ing, what made the patient tick, or what made them get
out of bed each morning despite the challenges. The re-
ceipt of additional resources delivered without clear con-
nection to the patient’s situation did not appear to
mitigate patients’ struggles to self-manage.
Finally, we presented the idea to our patient advisory
group as exploring how to have conversations about
their situation with clinicians so as to better align the
treatment plans developed to the circumstances of each
patient’s life and to patient ability to enact these plans.
At first, participants struggled with this concept; it was
clearly foreign to them, even after years of living with
chronic conditions. Midway, a patient boldly interjected:
“You mean the doctor might ask me how I am coping
with my disease? Well, that would change the world.”
The discussion that followed highlighted the importance
of patients’ ability to adapt and self-manage so that
illness and health care not disrupt the life they found
value in living.
Phase II
These key findings informed the development of our
prototypes. The three prototypes that we developed in-
cluded a deck of cards the patient could hold and two
different paper diagrams that clinicians could fill as they
had a conversation with the patient (Fig. 2). The proto-
types: 1) were embedded in the beginning of the clinical
encounter, to prevent information about patient context
emerging haphazardly, disjointedly, or too late to in-
form the treatment plan; 2) used more open-ended
opening questions; 3) brought out contextual informa-
tion beyond resources (e.g., finances, instrumental sup-
port, etc.); and 4) did not quantify patients’ capacity,
but rather elicited this information through dialogue
between patients and clinicians.
In Phase II, we observed that the prototypes showed the
most promise when they were shared between patient and
clinician. In other words, there needed to be more than a
clinician checklist. The words that we used to describe pa-
tient capacity (Physical, Emotional, Personal, Financial,
Social, and Environmental) were friendlier to researchers
and physicians than to patients. To fully allow patients to
participate, these needed to be reconsidered. The opening
question “What makes you famous?” had the intended ef-
fect of allowing life information to be permissible in the
conversation, and in some cases brought out fun and
insightful information. In other instances, it felt awkward
and warranted reconsideration.
Phase III
The three new prototypes contained the original four
design principles, but offered three opening questions
instead of one, each serving a specific purpose, and used
language friendlier to patients. The prototypes included
a clinician question sheet, and three different patient-
filled sheets. Each patient-filled sheet was tried separ-
ately, in combination with the clinician questions (Fig. 3).
This round of prototyping sought to contrast two differ-
ent ways of discussing patient capacity. The first one
elicited patient concerns. The second invited patients to
indicate whether each area of their life was a source of
satisfaction/help, a burden, or both. This latter approach
seemed more effective in creating the conversations we
Fig. 2 Phase II Prototypes
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intended to promote than the focus on specific con-
cerns. When discussing concerns, conversation often fell
flat. Patients either felt uncomfortable discussing them,
or didn’t perceive things as “concerns,” and didn’t bring
them up. The design underwent refinement in phase IV,
building on the dynamic tradeoffs patients needed to
make in their lives.
Phase IV
When discussing areas of their life, we observed that pa-
tients discussed tradeoffs or competing priorities. For
example, a patient mentioned that she and her husband
lived in an elderly community cooperative. While this
offered distinct socialization and safety benefits at their
age, there were many fellow dwellers that used wheel-
chairs or canes. Since they did not require physical aids,
this was sometimes depressing and made the patient
think if that would be their future as well. We had expli-
citly asked about consequences of areas of their life and
obstacles to overcome as a result, but such prompting
was mostly unnecessary. We hypothesized that patients
were also making similar tradeoffs in the healthcare
work they had been asked to do, either among compet-
ing healthcare tasks or competing life priorities. There-
fore, we modified the prototype to remove additional life
prompts. We also inserted a column to ask patients
about the things that they had been asked to do to care
for their health. At first, we populated this list for the
patient. However, we quickly moved to a version that pa-
tients could populate for themselves and learned they
were skillful in stating what they had been asked to do.
Our final modifications to the prototype included a
change from a color version to black and white, and to
reorder the list of items in the “life” column. We learned
from stakeholder feedback, that older patients struggled
with the color contrast and preferred a highly con-
trasted, black-and-white version. Additionally, our stake-
holders indicated that it might be useful to group the list
by what clinicians generally handle versus issues that call
for other team members to take part in the care of the
patient. The first group, from My Family and Friends to
Faith and Personal Meaning, identifies important con-
textual factors that clinicians recognize, if nothing to else
to enroll social workers, community health workers,
wellness coaches, and others in addressing these. The
second group, from Being Active to Eating Well, repre-
sents contextual factors on which clinicians could inter-
vene directly.
We observed clinicians and health professionals share
the patient-filled portion of the discussion aid in multiple
ways. Some began by asking about a burden, some about
a satisfaction. However, the questions, “what stands out to
you?” or “tell me a little bit about what you’ve filled here”
appeared to spark the most conversation.
Finalizing
We deemed the ICAN Discussion Aid (Fig. 4) finished
when we began to notice distinct changes in the patient-
clinician conversation from our initial observations. Con-
versations using the final prototype brought up contextual
issues of patient capacity and treatment burden early,
highlighting the competing priorities in life and health-
care, and in many cases resulting in changes to treatment
plans (Fig. 5). Furthermore, when we observed the proto-
type’s use with other health professionals, it did not re-
quire any modifications, demonstrating its versatility.
Briefly, the final version of the ICAN discussion aid is
used in the following way: while waiting for the clinician,
Fig. 3 Phase III Prototypes
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the patient takes ~3 min to fill ICAN. The clinician asks
one or more of three opening questions, which are used
in conversation but not depicted to the patient: 1) “What
are you doing when you’re not sitting here with me?”
brings forth information about typical day-to-day and
competing priorities, important for formulating treat-
ment fit. 2) “Where do you find the most joy?” allows
clinicians to assess if the patient is struggling with bio-
graphical disruption from their treatment and illness
[22–24], as well as ensure that treatment ties to or does
not overwhelm the patient’s meaning-making activities
(family or community life, work, hobbies), and 3)
“What’s on your mind today?” focuses on the visit today,
but without unnecessarily narrowing the options to
healthcare concerns. The clinician then explores what
the patient filled by asking “what stands out to you on
this sheet you filled?” The leftmost patient-filled column
is designed for maximum clinical efficiency and team co-
ordination. The first group of items, from “My Family
and Friends” to “Faith and Personal Meaning,” identifies
coping sources. If serious problems exist in these areas,
clinicians may want to enroll social workers, community
Fig. 4 Final ICAN Discussion Aid
Fig. 5 Encounter Highlights
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health workers, health coaches, and others to address
them. The second group, from “Being Active” to “Eating
Well,” represents health issues on which clinicians’ can
intervene directly. When used by other healthcare pro-
fessionals, they may be able to intervene directly on the
first group of items, whereas they may need to reach out
to the patient’s clinician to discuss the second group. Fi-
nally, the second column of ICAN elicits the demands




We set out to develop a Discussion Aid for use in clin-
ical encounters by patients and clinicians to assess pa-
tient’s capacity to handle the work of being a patient in
the context of their lives. Through a rigorous, user-
centered design process, we have created the ICAN Dis-
cussion Aid. This aid demonstrates early evidence of
success in illuminating how patients’ lives and health
care interact. ICAN can be used to inform longitudinal
relationships between patients and their healthcare team
across a broad range of healthcare professionals.
Limitations and strengths
The user-centered design process that informed the de-
velopment of the aid is a considerable strength of this
work. Rather than informing our design through formal
focus groups or in the conference rooms of researchers
and clinicians, we took our design directly to the prac-
tice. This was purposeful to ensure that the final ICAN
Discussion Aid would be novel, practical, useful, and
friendly to clinicians, health professionals, and their pa-
tients. Another strength of ICAN’s design is its ability to
open up a range of hypotheses for patients and their
healthcare team to explore together. For example, for
new patients, clinicians can quickly get to know their pa-
tient, what might work in their context, and why certain
treatment plans might be problematic. This approach
surfaces concerns immediately, but also establishes a
firm foundation for future interaction. In ongoing
patient-clinician relationships, where communication or
progress is stalled, ICAN may uncover hypotheses for
why this is the case. This strength is notable when com-
pared to previous assessments of function. For example,
Huber suggests measuring health as functioning using
The COOP/Wonca Functional Health Assessment
Charts. These present six different dimensions of health
scored 1 to 5, each supported by drawings [3, 25]. These
assessments quantify some elements of capacity, which
may not tell the full story, and when practitioners must
cumulatively assess many domains at one time, can be-
come increasingly cumbersome in the clinical encounter.
Furthermore, our observations suggest that quantifying
capacity may not necessarily engage two parties in a dis-
cussion about the results.
These strengths are not without limitations. For ex-
ample, we cannot conclude that ICAN will be useful in
all situations or for all clinicians, or that its use will im-
prove patient outcomes, all outside the bounds of this
stage of our project. Future research will need to study
the impact of ICAN on the clinical encounter, the pa-
tient’s relationship with their clinicians and healthcare
teams, their burden of treatment and illness, and on
patient-centered health outcomes.
Implications for practice
The ICAN Discussion Aid is the first discussion aid that
can be implemented into practice in pursuit of Minim-
ally Disruptive Medicine [4]. Specifically, it provides an
avenue for clinicians to implement three of the four
principles of MDM. First, it illuminates the necessary in-
formation to establish the burden of treatment offering
clinicians hypotheses to answer, “what is the most effect-
ive least burdensome treatment for this person now?”
Consider three otherwise similar patients with uncon-
trolled type 2 diabetes. By using ICAN, a clinician learns
that one has a strong social network and travels exten-
sively for work; that the other is a farmer who spends
time out in the fields and worrying about his fluctuating
income; and that the other is retired and spends time
enjoying her home, but with almost no social support.
The most effective, least burdensome treatment program
to improve diabetes control in each of these patients will
likely be different.
Second, ICAN can be used to encourage coordination
in clinical practice. Future research should seek to
understand how health systems can organize care teams
around this new-found understanding of each patient’s
capacity, which is more meaningful than the current so-
cial history found in electronic health records. Third,
and likely most importantly, it allows patients and their
healthcare team to prioritize care from the patient per-
spective. ICAN underscores what the patient values
doing and being in life, i.e., what does their normal day
look like and where do they find joy, and provides the
building blocks of a conversation that can prioritize care
around how health care and life can work in synergy to
support that perspective.
Ultimately, the opening of these possibilities estab-
lishes meaningful relationships with patients and their
healthcare team, and may lead to treatment plans that
are more likely to fit within the patient’s life. Based on
the conceptual underpinnings of Minimally Disruptive
Medicine and related theories and frameworks, these
changes should positively impact the patient’s ability to
access and use healthcare and enact self-care, and ultim-
ately experience favorable health outcomes [5]. We hope
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that attending to patient’s capacity can also help elimin-
ate contextual errors in care [26]. Furthermore, ICAN’s
implementation should improve health care’s own cap-
acity to cope with the task of organizing and delivering
care to more complex patients including those with
MCC and helping them achieve the ability to adapt and
self-manage in the face of chronic disease.
Conclusion
Through a rigorous user-centered design process, we
developed the ICAN Discussion Aid, which should sup-
port clinical conversations that acknowledge, respect,
and support the underappreciated work of being a pa-
tient and patients’ capacity to carry out that work.
These conversations should support longitudinal rela-
tionships with patients and their healthcare teams that
further patients’ ability to adapt and self-manage while
pursing meaningful lives. ICAN deserves future testing
to determine its efficacy in promoting Minimally Dis-
ruptive Medicine.
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